ABC transporters affect the detection of intracellular oxidants by fluorescent probes

Free Radical Research

Volumn 45, Issue 7, 2011, Pages 779-787

  Procházková, Jiřina ^a   Kubala, Lukáš ^b   Kotasovǎ, Hana ^a   Gudernovǎ, Iva ^a   Šrǎmkovǎ, Zuzana ^a   Pekarovǎ, Michaela ^b   Sarkadi, Balǎzs ^c   Pachernǐk, Jiří ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Fluorescence; mitochondria; reactive oxygen species (ROS); redox status

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CYTOCHROME C; DICHLORODIHYDROFLUORESCEIN; DIHEXYLOXOCARBOCYANINE IODIDE; DIHYDRORHODAMINE 123; FLUORESCENT DYE; HYDROETHIDINE; LUMINOL; MULTIDRUG RESISTANCE PROTEIN 1; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; TETRACHLOROTETRAETHYLBENZIMIDAZOLOCARBOCYANINE IODIDE; TETRAMETHYLRHODAMINE ETHYL ESTER PERCHLORATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CELL LEVEL; CELL STRAIN HL 60; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ASSAY; FLUORESCENCE; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; FLUORESCENT DYES; HL-60 CELLS; HUMANS; INTRACELLULAR SPACE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; OXIDANTS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79957924106     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2011.579120     Document Type: Article

References (50)

1. Ma Q. Transcriptional responses to oxidative stress: pathological and toxicological implications. Pharmacol Ther 2010; 125:376-393.
2. Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 2000;28:1456-1462. (Pubitemid 30604227)
3. Hernandez-Garcia D, Wood CD, Castro-Obregon S, Covarrubias L. Reactive oxygen species: a radical role in development? Free Radic Biol Med 2010;49(2):130-43.
4. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE. Mitochondria and reactive oxygen species. Free Radic Biol Med 2009;47:333-343.
5. Soh N. Recent advances in fluorescent probes for the detec-tion of reactive oxygen species. Anal Bioanal Chem 2006;386: 532-543. (Pubitemid 44450932)
6. Dickinson BC, Srikun D, Chang CJ. Mitochondrial-targeted fluorescent probes for reactive oxygen species. Curr Opin Chem Biol 2009;14:50-56.
7. Ozben T. Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett 2006;580:2903-2909. (Pubitemid 43729172)
8. Raaijmakers MH. ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia. Leukemia 2007;21:2094-2102. (Pubitemid 47430452)
9. Stavrovskaya AA, Stromskaya TP. Transport proteins of the ABC family and multidrug resistance of tumor cells. Biochemistry (Mosc) 2008;73:592-604. (Pubitemid 351775081)
10. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF, Mori M. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 2006;24:506-513. (Pubitemid 44464754)
11. Huls M, Russel FG, Masereeuw R. The role of ATP binding cassette transporters in tissue defense and organ regeneration. J Pharmacol Exp Ther 2009;328:3-9.
12. Abbott BL. ABCG2 (BCRP) expression in normal and malig-nant hematopoietic cells. Hematol Oncol 2003;21:115-130. (Pubitemid 37305331)
13. Li X, Leder P. Identifying genes preferentially expressed in undifferentiated embryonic stem cells. BMC Cell Biol 2007; 8:37.
14. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, Sorrentino BP. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001;7:1028-1034. (Pubitemid 32937383)
15. Apati A, Orban TI, Varga N, Nemeth A, Schamberger A, Krizsik V, et al. High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. Biochim Biophys Acta 2008;1778:2700-2709.
16. Ozvegy-Laczka C, Hegedus T, Varady G, Ujhelly O, Schuetz JD, Varadi A, et al. High-affi nity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter. Mol Phar-macol 2004;65:1485-1495. (Pubitemid 38668306)
17. Soucek K, Pachernik J, Kubala L, Vondracek J, Hofmanova J, Kozubik A. Transforming growth factor-beta1 inhibits all-trans retinoic acid-induced apoptosis. Leuk Res 2006;30: 607-623. (Pubitemid 43374590)
18. Pavelkova M, Kubala L. Luminol-, isoluminol-and lucigenin-enhanced chemiluminescence of rat blood phagocytes stimu-lated with different activators. Luminescence 2004;19:37-42. (Pubitemid 40341049)
19. Rudolph TK, Rudolph V, Edreira MM, Cole MP, Bonacci G, Schopfer FJ, et al. Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-defi cient mice. Arterioscler Thromb Vasc Biol 2010;30:938-945.
20. Vesela I, Kotasova H, Jankovska S, Prochazkova J, Pachernik J. Leukaemia inhibitory factor inhibits cardiomyogenesis of mouse embryonic stem cells via STAT3 activation. Folia Biol (Praha) 2010;56:165-172.
21. Prochazkova J, Stixova L, Soucek K, Hofmanova J, Kozubik A. Monocytic differentiation of leukemic HL-60 cells induced by co-treatment with TNF-alpha and MK886 requires activation of pro-apoptotic machinery. Eur J Haematol 2009;83:35-47.
22. Hollo Z, Homolya L, Davis CW, Sarkadi B. Calcein accumu-lation as a fl uorometric functional assay of the multidrug transporter. Biochim Biophys Acta 1994;1191:384-388. (Pubitemid 24183562)
23. Robey RW, Honjo Y, van de Laar A, Miyake K, Regis JT, Litman T, Bates SE. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2). Biochim Biophys Acta 2001;1512:171-182. (Pubitemid 32530764)
24. Ambrozova G, Pekarova M, Lojek A. Effect of polyunsatu-rated fatty acids on the reactive oxygen and nitrogen species production by raw 264.7 macrophages. Eur J Nutr 2010;49: 133-139.
25. LeBel CP, Ischiropoulos H, Bondy SC. Evaluation of the probe 2 ',7 '-dichlorofl uorescin as an indicator of reactive oxy-gen species formation and oxidative stress. Chem Res Toxicol 1992;5:227-231.
26. Bucana CD, Giavazzi R, Nayar R, O'Brian CA, Seid C, Earnest LE, Fan D. Retention of vital dyes correlates inversely with the multidrug-resistant phenotype of adriamycin-selected murine fi brosarcoma variants. Exp Cell Res 1990;190: 69-75.
27. Masereeuw R, Moons MM, Russel FG. Rhodamine 123 accumulates extensively in the isolated perfused rat kidney and is secreted by the organic cation system. Eur J Pharmacol 1997;321:315-323. (Pubitemid 27105934)
28. van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD. Specifi city of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. Eur J Pharm Sci 2000;11:207-214. (Pubitemid 30616443)
29. Nare B, Prichard RK, Georges E. Characterization of rhod-amine 123 binding to P-glycoprotein in human multidrug-resistant cells. Mol Pharmacol 1994;45:1145-1152. (Pubitemid 24195572)
30. Kataoka M, Fukura Y, Shinohara Y, Baba Y Analysis of mito-chondrial membrane potential in the cells by microchip fl ow cytometry. Electrophoresis 2005;26:3025-3031. (Pubitemid 41167668)
31. Hasmann M, Valet GK, Tapiero H, Trevorrow K, Lampidis T Membrane potential differences between adriamycin-sensitive and-resistant cells as measured by flow cytometry. Biochem Pharmacol 1989;38:305-312. (Pubitemid 19033341)
32. Hendrich AB, Wesolowska O, Pola A, Motohashi N, Molnar J, Michalak K. Neither lipophilicity nor membrane-perturbing potency of phenothiazine maleates correlate with the ability to inhibit P-glycoprotein transport activity. Mol Membr Biol 2003;20:53-60. (Pubitemid 36460646)
33. Vasconcelos FC, Cavalcanti GB, Jr, Silva KL, de Meis E, Kwee JK, Rumjanek VM, Maia RC. Contrasting features of MDR phenotype in leukemias by using two fl uorochromes: implications for clinical practice. Leuk Res 2007;31: 445-454. (Pubitemid 46198938)
34. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franc-eschi C A new method for the cytofl uorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5 ',6,6 '-tetrachloro-1,1 ',3,3 '-tetra-ethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Bio-phys Res Commun 1993;197:40-45. (Pubitemid 23358874)
35. Kuhnel JM, Perrot JY, Faussat AM, Marie JP, Schwaller MA. Functional assay of multidrug resistant cells using JC-1, a carbocyanine fluorescent probe. Leukemia 1997;11: 1147-1155. (Pubitemid 27345969)
36. Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu SW, et al. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 2002;158:507-517. (Pubitemid 34851709)
37. Rajagopal A, Pant AC, Simon SM, Chen Y In vivo analysis of human multidrug resistance protein 1 (MRP1) activity using transient expression of fluorescently tagged MRP1. Cancer Res 2002;62:391-396. (Pubitemid 34106410)
38. Rajagopal A, Simon SM. Subcellular localization and activity of multidrug resistance proteins. Mol Biol Cell 2003;14: 3389-3399. (Pubitemid 37013135)
39. Olson DP, Taylor BJ, Ivy SP. Detection of MRP functional activity: calcein AM but not BCECF AM as a Multidrug Resistance-related Protein (MRP1) substrate. Cytometry 2001;46:105-113. (Pubitemid 32423461)
40. Krejcova D, Prochazkova J, Kubala L, Pachernik J. Modulation of cell proliferation and differentiation of human lung carcinoma cells by the interferon-alpha. Gen Physiol Biophys 2009;28:294-301.
41. Walter DH, Haendeler J, Galle J, Zeiher AM, Dimmeler S. Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria. Circulation 1998;98:1153-1157. (Pubitemid 28436163)
42. Cirino M, Motz C, Maw J, Ford-Hutchinson AW, Yano M. BQ-153, a novel endothelin (ET)A antagonist, attenuates the renal vascular effects of endothelin-1. J Pharm Pharmacol 1992;44:782-785.
43. Gekeler V, Ise W, Sanders KH, Ulrich WR, Beck J. The leukotriene LTD4 receptor antagonist MK571 specifi cally modulates MRP associated multidrug resistance. Biochem Biophys Res Commun 1995;208:345-352.
44. Cui CB, Kakeya H, Okada G, Onose R, Osada H. Novel mammalian cell cycle inhibitors, tryprostatins A, B and other diketopiperazines produced by Aspergillus fumigatus. I. Taxonomy, fermentation, isolation and biological properties. J Antibiot (Tokyo) 1996;49:527-533. (Pubitemid 26235660)
45. Boumendjel A, Nicolle E, Moraux T, Gerby B, Blanc M, Ronot X, Boutonnat J. Piperazinobenzopyranones and phenalkylaminobenzopyranones: potent inhibitors of breast cancer resistance protein (ABCG2). J Med Chem 2005;48: 7275-7281. (Pubitemid 41743640)
46. Solazzo M, Fantappie O, D'Amico M, Sassoli C, Tani A, Cipriani G, et al. Mitochondrial expression and functional activity of breast cancer resistance protein in different multiple drug-resistant cell lines. Cancer Res 2009;69: 7235-7242.
47. Jeong JM, Choi CH, Kang SK, Lee IH, Lee JY, Jung H. Antioxidant and chemosensitizing effects of fl avonoids with hydroxy and/or methoxy groups and structure-activity rela-tionship. J Pharm Pharm Sci 2007;10:537-546.
48. Dvorakova K, Payne CM, Tome ME, Briehl MM, Vasquez MA, Waltmire CN, et al. Molecular and cellular characteriza-tion of imexon-resistant RPMI8226/I myeloma cells. Mol Cancer Ther 2002;1:185-195.
49. Bustamante J, Caldas Lopes E, Garcia M, Di Libero E, Alvarez E, Hajos SE. Disruption of mitochondrial membrane potential during apoptosis induced by PSC 833 and CsA in multidrug-resistant lymphoid leukemia. Toxicol Appl Phar-macol 2004;199:44-51. (Pubitemid 39099454)
50. Sun W, Wang W, Kim J, Keng P, Yang S, Zhang H, et al. Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment. Adv Exp Med Biol 2008;614:179-186.